Upsher-Smith announced the launch of Dicyclomine Hydrochloride Capsules, USP 10 mg. The company now offers the product in tablet and capsule forms.
The dicyclomine hydrochloride capsule market had U.S. sales of approximately $36.8M for the 12 months ending March 2023 according to IQVIA.